Nitric oxide attenuates platelet-activating factor priming for elastase release in human neutrophils via a cyclic guanosine monophosphate-dependent pathway.

Find People
Find Research
Overview
Tutorials
FAQs
Edit My PROFILE
Login to PROFILES

Contact Us
If you have any questions or feedback please contact us.

Nitric oxide attenuates platelet-activating factor priming for elastase release in human neutrophils via a cyclic guanosine monophosphate-dependent pathway.

Partrick DA, Moore EE, Offner PJ, Barnett CC, Barkin M, Silliman CC. Nitric oxide attenuates platelet-activating factor priming for elastase release in human neutrophils via a cyclic guanosine monophosphate-dependent pathway. Surgery. 1997 Aug; 122(2):196-202; discussion 202-3.

View in: PubMed

subject areas

Adult
Analysis of Variance
Cyclic GMP
Dibutyryl Cyclic GMP
Humans
In Vitro Techniques
Kinetics
Leukocyte Elastase
Models, Biological
Molsidomine
Neutrophils
Nitric Oxide
Platelet Activating Factor
Signal Transduction
Substrate Specificity

authors with profiles

David A Partrick

Contact Us
CCTSI
About CCTSI
CCTSI Affiliated Institutions
National CTSA Consortium